Amneal intros generic Tamiflu for oral suspension

Press enter to search
Close search
Open Menu

Amneal intros generic Tamiflu for oral suspension

By David Salazar - 03/01/2018
Amneal Pharmaceuticals has introduced its generic Tamiflu for oral suspension (oseltamivir phosphate, 6 mg/ml). The Bridgewater, N.J.-based company's product is a powder finished dosage that is packaged in bottles with 60 ml of usable volume following constitution.

Amneal's generic Tamiflu for oral suspension joins generic Tamiflu capsules that it launched in July 2017.

"Approval and launch of this liquid form should be of great assistance to patients and caregivers," Amneal executive vice president of commercial operations Andy Boyer said. "With a severe flu season upon us, our product should be able to help provide relief to thousands of patients. We are pleased to provide this liquid dosage form to patients, particularly the elderly and young who are unable to use an oral solid form."

The drug is indicated to prevent the flu and as a treatment in patients who have been symptomatic for less than 48 hours. The drug's market size was roughly $956 million for the 12 months ended December 2017, according to IQVIA data.

Related Topics